Posted by Michael Wonder on 16 Jan 2023
Angiotensin II acetate for the treatment of patients with vasosuppressor-resistant hypotension caused by septic or distributive shock
16 January 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use of angiotensin II acetate in the NHS in England.
NICE is unable to make a recommendation on the use of angiotensin II acetate for the treatment of patients with vasosuppressor-resistant hypotension caused by septic or distributive shock because Paion did not provide an evidence submission.
